Jerry Conway provides a DNA-centric view of organizing treatment plans with respect to the use of some advances in genomic technology.
Jerry Conway provides a DNA-centric view of organizing treatment plans with respect to the use of some advances in genomic technology.
Mr Conway relates how patient-centered innovation hits close to home to his own personal experiences. “My one son says Dad, the title of the movie of your life is DNA Gone Bad,” he says, “and if you think about cancer, that’s what it is: DNA gone bad.”
He explains how his organization, Foundation Medicine, envisions itself as a “molecular information company” rather than a diagnostics company. They have focused on leading the transformation of cancer care, where “each patient’s diagnosis and treatment is informed by a deep understanding of the molecular changes that drive their disease.” Foundation Medicine believes there is an opportunity in collaboration with a number of stakeholders across the country and that they can make significant improvements in the safety, efficacy, and affordability of cancer treatment using genomic approaches.
“So, cancer is a disease of the genome and when the DNA goes bad—as my son likes to say—that’s when cancer starts. So, this is certainly a new frontier in terms of thinking about the disease in genomic terms, as opposed to histological terms only,” Mr Conway explains. “So, we see a migration from a histological view to a histomolecular view, and perhaps over time—with evidence—a molecular characterization of the disease in which the treatments are organized on a genomic basis.”
He also details other challenges and opportunities his organization has experienced with genetic testing in oncology.
Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America
May 6th 2024CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen